Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Sep;6(3):273–278. doi: 10.1111/j.1365-2125.1978.tb04597.x

Liver size and indices of drug metabolism in epileptics.

H I Pirttiaho, E A Sotaniemi, J T Ahokas, U Pitkänen
PMCID: PMC1429461  PMID: 687506

Abstract

1 The relationship between liver size and in vivo (antipyrine kinetics) and in vitro (cytochrome P-450) drug metabolism was investigated in twenty-one epileptics on long-term anticonvulsant therapy and in controls. 2 The epileptics exhibited significant enlargement of the liver and enhancement of drug metabolism compared to the controls. 3 Liver size correlated to antipyrine kinetics only in controls. Concentration of cytochrome P-450 in liver biopsy specimens correlated with liver size neither in controls nor in epileptics. 4 The total hepatic cytochrome P-450, estimated on the basis of liver weight and cytochrome P-450 concentration of biopsy samples, correlated linearly with antipyrine kinetics, except in patients with the most severely disturbed liver architecture. 5 Measurement of liver size is essential when comparing in vivo and in vitro drug metabolism, but the changes in liver histology are also of great importance.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODIE B. B., AXELROD J. The fate of antipyrine in man. J Pharmacol Exp Ther. 1950 Jan;98(1):97–104. [PubMed] [Google Scholar]
  2. Barka T., Popper H. Liver enlargement and drug toxicity. Medicine (Baltimore) 1967 Mar;46(2):103–117. doi: 10.1097/00005792-196703000-00005. [DOI] [PubMed] [Google Scholar]
  3. Billng B. H., Black M. The action of drugs on bilirubin metabolism in man. Ann N Y Acad Sci. 1971 Jul 6;179:403–410. doi: 10.1111/j.1749-6632.1971.tb46917.x. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N., Khatri I. M., Groszmann R. J., Kotelanski B. Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic. Am J Med. 1972 Dec;53(6):704–714. doi: 10.1016/0002-9343(72)90187-8. [DOI] [PubMed] [Google Scholar]
  5. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  6. Greim H., Schenkman J. B., Klotzbücher M., Remmer H. The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim Biophys Acta. 1970 Jan 27;201(1):20–25. doi: 10.1016/0304-4165(70)90005-x. [DOI] [PubMed] [Google Scholar]
  7. Groszmann R., Kotelanski B., Cohn J. N., Khatri I. M. Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. Am J Med. 1972 Dec;53(6):715–722. doi: 10.1016/0002-9343(72)90188-x. [DOI] [PubMed] [Google Scholar]
  8. Imai Y., Sato R. Substrate interaction with hydroxylase system in liver microsomes. Biochem Biophys Res Commun. 1966 Mar 22;22(6):620–626. doi: 10.1016/0006-291x(66)90191-4. [DOI] [PubMed] [Google Scholar]
  9. KATO R., FRONTINO G., VASSANELLI P. Phenobarbital markedly increases liver weight in Walker carcinosarcoma bearing rats. Experientia. 1963 Jan 15;19:30–31. doi: 10.1007/BF02135342. [DOI] [PubMed] [Google Scholar]
  10. Pirttiaho H. I., Sotaniemi E. A., Ahlqvist J., Pitkänen U., Pelkonen R. O. Liver size and indices of drug metabolism in alcoholics. Eur J Clin Pharmacol. 1978 Mar 17;13(1):61–67. doi: 10.1007/BF00606684. [DOI] [PubMed] [Google Scholar]
  11. Prescott L. F., Adjepon-Yamoah K. K., Roberts E. Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol. 1973 Mar;25(3):205–207. doi: 10.1111/j.2042-7158.1973.tb10625.x. [DOI] [PubMed] [Google Scholar]
  12. REMMER H., MERKER H. J. EFFECT OF DRUGS ON THE FORMATION OF SMOOTH ENDOPLASMIC RETICULUM AND DRUG-METABOLIZING ENZYMES. Ann N Y Acad Sci. 1965 Mar 12;123:79–97. doi: 10.1111/j.1749-6632.1965.tb12247.x. [DOI] [PubMed] [Google Scholar]
  13. Remmer H., Schenkman J., Estabrook R. W., Sasame H., Gillette J., Narasimhulu S., Cooper D. Y., Rosenthal O. Drug interaction with hepatic microsomal cytochrome. Mol Pharmacol. 1966 Mar;2(2):187–190. [PubMed] [Google Scholar]
  14. Roberts C. J., Jackson L., Halliwell M., Branch R. A. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol. 1976 Oct;3(5):907–913. doi: 10.1111/j.1365-2125.1976.tb00646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rollo F. D., DeLand F. H. The determination of liver mass from radionuclide images. Radiology. 1968 Dec;91(6):1191–1194. doi: 10.1148/91.6.1191. [DOI] [PubMed] [Google Scholar]
  16. Schulte-Hermann R. Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol. 1974 Sep;3(1):97–158. doi: 10.3109/10408447409079856. [DOI] [PubMed] [Google Scholar]
  17. Schulte-Hermann R., Leberl C., Landgraf H., Koransky W. Liver growth and mixed-function oxidase activity: dose-dependent stimulatory and inhibitory effects of alpha-hexachlorocyclohexane. Naunyn Schmiedebergs Arch Pharmacol. 1974;285(4):355–366. doi: 10.1007/BF00501464. [DOI] [PubMed] [Google Scholar]
  18. Silvestrini B., Catanese B., Del Basso P. Researches on the increase of liver weight produced by some drugs. Biochem Pharmacol. 1966 Mar;15(3):249–254. doi: 10.1016/0006-2952(66)90295-4. [DOI] [PubMed] [Google Scholar]
  19. Sotaniemi E. A., Kontturi M. J., Larmi T. K. Drug metabolism and androgen control therapy in prostatic cancer. Clin Pharmacol Ther. 1973 May-Jun;14(3):413–417. doi: 10.1002/cpt1973143413. [DOI] [PubMed] [Google Scholar]
  20. Sotaniemi E. A., Pelkonen R. O., Ahokas J., Pirttiaho H. I., Ahlqvist J. Drug metabolism in epileptics: in vivo and in vitro correlations. Br J Clin Pharmacol. 1978 Jan;5(1):71–76. doi: 10.1111/j.1365-2125.1978.tb01600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wilkinson G. R., Schenker S. Effects of liver disease on drug disposition in man. Biochem Pharmacol. 1976 Dec 15;25(24):2675–2681. doi: 10.1016/0006-2952(76)90256-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES